ABOUT CONOLIDINE

Andy Chevigné and his workforce, RTI-5152-12 is postulated to enhance the levels of opioid peptides that bind to classical opioid receptors from the brain, resulting in heightened painkilling activity. The LIH-RTI research groups set up a collaboration arrangement and filed a joint patent software in December 2020.Just before we proceed any even f